Brief: Isofol's Rights Issue Oversubscribed
June 3 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* ISOFOL'S RIGHTS ISSUE OVERSUBSCRIBED
* THROUGH RIGHTS ISSUE AND OVER-ALLOTMENT OPTION, ISOFOL
WILL
RECEIVE PROCEEDS AMOUNTING TO APPROXIMATELY SEK 180 MILLION
BEFORE TRANSACTION COSTS.
Source text for Eikon: ID:nWkrtzLk1
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical reports no Q2 revenue, net loss widens
Brief: Isofol Medical Q2 Net Income SEK -15.729 Million
Brief: Isofol Medical Adds Clinical Trial Sites To Phase Ib/Ii Arfolitixorin Study In Colorectal Cancer
Sweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million